Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
August 14, 2024 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today announced the company...
Nautilus Biotechnology Reports Second Quarter 2024 Financial Results
July 30, 2024 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, July 30, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial...
Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024
July 09, 2024 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, July 09, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule protein analysis platform, today announced it will...
Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
May 23, 2024 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, May 23, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company...
Nautilus Biotechnology Reports First Quarter 2024 Financial Results
April 30, 2024 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, April 30, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported financial...
Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024
April 11, 2024 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, April 11, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule protein analysis platform, today announced it will...
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results
February 28, 2024 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported financial...
Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare Conference
February 22, 2024 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company...
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
February 07, 2024 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule protein analysis platform, today announced it will...
Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award
November 30, 2023 08:00 ET
|
Nautilus Biotechnology Inc.
SEATTLE, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome,...